샘플 요청 목록

 카트 문의
시장보고서
상품코드
1944416

계산 병리학 시장 : 기술별, 제품 종류별, 워크플로우 단계별, 전개 방식별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Computational Pathology Market, By Technology, By Product Type, By Workflow Stage, By Deployment Mode, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 365 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

계산 병리학 시장 규모는 2024년에 6억 5,098만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 9.30%로 확대될 전망입니다.

계산 병리학은 의료 조직과 병리학자를 지원하기 위해 고안된 첨단 디지털 시스템을 말합니다. 진단, 분석, 업무 활동에 대한 자동화된 지원을 제공하며, 인공지능(AI), 머신러닝(ML), 이미지 인식 등의 기술을 활용하여 디지털 병리 슬라이드 분석, 패턴 감지, 바이오마커 정량화, 실용적인 지식 생성 등을 수행합니다. 이러한 시스템은 진단 정확도 향상, 인적 오류 감소, 병리 워크플로우의 효율화에 기여하고, 검사 결과를 신속하게 제공할 수 있습니다. 이미지 세분화 및 데이터 어노테이션과 같은 일상적인 작업을 자동화함으로써 계산 병리학은 수작업의 부담을 줄이고 검사실의 효율성을 높입니다. 또한, 병리학자 및 임상의에게 정밀한 데이터 기반 지식을 제공함으로써 임상적 의사결정을 지원합니다. 또한, 계산 병리학 솔루션은 접근 가능한 디지털 기반 진단 서비스의 확장을 촉진하고, 환자 치료 결과를 개선하며, 의료 분야의 대규모 연구 이니셔티브를 지원합니다.

계산 병리학의 시장 역학

디지털 병리 플랫폼 활용 확대

디지털 병리 플랫폼의 이용 확대는 병리학자 및 의료기관이 병리 데이터를 보다 효율적으로 관리, 분석, 공유할 수 있는 첨단 디지털 시스템 도입이 증가하는 것을 의미합니다. 이를 통해 고해상도 병리 영상, AI 알고리즘, 분석 애플리케이션을 검사실 및 임상 환경에 통합하여 진단 정확도와 워크플로우 효율성을 향상시킬 수 있습니다. 계산 병리학에서 이러한 플랫폼은 이미지 분석의 자동화, 실시간 데이터 해석, 조직 샘플의 정량적 평가를 지원합니다. 그 결과, 병리과 의사는 보다 빠른 결과 도출, 수작업의 부담 감소, 전반적인 진단 성능 향상을 실현할 수 있습니다. 또한, 디지털 병리 플랫폼을 검사 정보 시스템(LIS) 및 전자건강기록(EHR)과 통합하여 원활한 데이터 흐름과 상호 운용성을 보장합니다. 이러한 플랫폼은 또한 데이터 기반 피드백을 통해 AI 모델의 지속적인 학습과 개선을 촉진합니다. 전반적으로 디지털 병리 플랫폼의 이용 확대는 현대 의료 시스템에서 계산 병리학 솔루션의 확장성, 신뢰성, 유효성을 강화하고 있습니다. 예를 들어, Frontiers in Digital Health가 2025년 9월에 발표한 요르단 내 디지털 병리 도입에 관한 연구에 따르면, 조사 대상 병리학자의 69.2%가 디지털 병리에 대해 평균 이상의 지식을 가지고 있으며, 85%가 진단 목적으로 디지털 병리 도구가 있다면 사용 가능한 경우 디지털 병리 도구를 사용할 의향이 있는 것으로 나타났습니다. 이는 신흥 의료 환경에서의 디지털 병리 확대에 대한 강력한 전문적 준비 태세와 관심을 반영합니다. 이러한 통계는 임상 현장의 진단 프로세스, 교육, 원격 액세스, 조사 능력 향상을 위한 디지털 병리학 기술의 통합을 향한 지속적인 추세를 보여줍니다.

계산 병리학 시장 : 세분화 분석

세계 계산 병리학 시장은 기술, 제품 유형, 워크플로우 단계, 배포 방식, 최종사용자, 지역을 기준으로 세분화되어 있습니다.

워크플로우 단계에 따른 시장 분류는 일반적으로 '분석 전 단계', '분석 단계', '분석 후 단계'의 세 가지로 나뉩니다. 분석 단계는 정확한 AI 기반 영상 분석, 효율적인 병리 해석, 적시 진단 보고를 가능하게 하는 역할로 인해 계산 병리학 시장에서 큰 비중을 차지하고 있습니다. 진단보고란 병리 소견 등 의료 검사 및 분석 결과를 명확하고 체계적인 형식으로 문서화하여 전달하는 과정을 말하며, 임상적 판단과 환자 진료의 지침이 됩니다. 이를 통해 영상 분석 최적화, 병리 워크플로우 효율화, 진단 프로세스 가속화, 적시에 정확한 결과를 보장할 수 있습니다. 분석 효율의 향상은 진단 정확도를 높이고, 병리학자의 업무 부담을 줄이며, 검사실이 더 많은 검체를 효율적으로 처리할 수 있도록 합니다. 계산 병리학에서 분석 단계의 효율성은 AI를 통한 이미지 해석, 조직 특징의 자동 정량화, 신속한 보고서 작성을 통해 달성됩니다. 이러한 시스템은 병리과 의사가 진단 결과를 신속하게 분석, 검증, 확정할 수 있도록 지원하여 수작업으로 인한 오류를 최소화하고 중요한 병리 결과에 보다 신속하고 안정적으로 접근할 수 있도록 돕습니다. 예를 들어, PNAS Nexus Organization 저널에 게재된 2025년 연구에 따르면, 소형 컨볼루션 신경망은 표준 조직 이미지를 사용하여 정상 림프절과 다양한 림프종 아형을 구분하는 데 있어 약 0.87의 진단 분류 정확도(AUC)를 달성한 것으로 보고되었습니다. AI 기반 계산병리학 도구의 임상 적용에 대한 높은 가능성을 보여주고 있습니다.

계산 병리학 시장은 기술에 따라 AI 기반 기술과 이미지 분석 및 시각화 기술의 두 가지 범주로 나뉩니다. AI 기반 기술 부문은 진단 정확도, 확장성, 분석 효율성을 향상시킬 수 있는 능력으로 인해 계산 병리학 시장에서 큰 비중을 차지하고 있습니다. 이러한 성장은 의료 투자 증가와 병리학 워크플로우의 첨단 디지털 기술 도입 확대에 의해 부분적으로 촉진되고 있습니다. AI 기반 기술의 확장성과 분석 능력은 알고리즘이 방대한 병리 이미지를 효율적으로 처리하면서 증가하는 데이터세트에서 일관된 성능을 유지할 수 있는 능력을 의미합니다. 이를 통해 검사실은 수작업이나 인프라의 복잡성을 비례적으로 증가시키지 않고도 진단 능력을 확장할 수 있습니다. 계산 병리학에서 AI 기반 기술은 조직 샘플의 자동 이미지 분석, 패턴 인식, 정량적 평가를 대규모로 실현합니다. 이러한 솔루션은 진단을 가속화하고, 병리학자의 업무 부담을 줄이며, 증가하는 데이터로부터 학습을 통해 지속적인 성능 향상을 지원하여 임상 및 연구 환경에서 신뢰성과 효율성을 겸비한 병리 서비스를 제공합니다. 예를 들어, 영국 정부의 '인공지능 부문 조사 2024'에 따르면, 2023년부터 2024년까지 영국의 AI 생태계는 눈에 띄게 확장되었으며, AI 부문의 총 수익은 전년 대비 약 68% 증가, AI 관련 일자리는 8만 6,139개로 증가하였습니다. 이는 산업 전반에 걸친 AI 기술의 급속한 경제 성장과 보급을 뒷받침합니다. 이러한 광범위한 보급은 디지털 병리 인프라의 성숙도가 높아지고 있으며, AI 기반 기술이 병리 데이터의 확장 가능한 분석을 가능하게 하고, 진단 시스템 간의 상호운용성을 향상시키며, 정확하고 효율적인 데이터 기반 임상 의사결정을 지원하는 지능형 전산 병리학 솔루션의 활용이 확대되고 있음을 보여줍니다. 솔루션의 활용 확대라는 보다 광범위한 트렌드를 반영하고 있습니다.

계산 병리학 시장 - 지역별 분석

계산 병리학 시장은 의료 인프라, 디지털 병리 도입 현황, 규제 환경의 차이에 따라 지역별로 현저한 차이를 보이고 있습니다. 북미는 첨단 진단 시설, AI 기반 병리 솔루션의 조기 통합, 강력한 연구 생태계, 미국 및 캐나다의 높은 도입률에 힘입어 북미 시장을 지속적으로 주도하고 있습니다. 유럽에서는 정밀 진단에 대한 투자 증가, 디지털 병리학에 대한 우호적인 규제 지원, 병리 워크플로우 전반에 걸친 AI 활용 확대에 힘입어 꾸준한 성장세를 보이고 있습니다. 아시아태평양은 의료의 디지털화 가속화, 암 부담 증가, AI 투자 확대, 중국, 인도, 일본, 한국 등의 정부 지원책으로 인해 빠르게 성장하고 있는 시장입니다. 한편, 라틴아메리카, 중동 및 아프리카에서는 검사 능력의 향상, 계산병리학 도구에 대한 인식 확대, 진단 효율성 및 접근성 향상 노력으로 시장이 점차 발전하고 있습니다.

미국 계산 병리학 시장 - 국가별 분석

미국의 계산 병리학 시장은 첨단 의료 인프라와 AI 기반 진단 기술의 통합 확대를 배경으로 꾸준한 성장세를 보이고 있습니다. 의료기관 및 병리검사실에서는 진단 정확도 향상, 검사실 워크플로우 최적화, 정밀의료 추진을 목적으로 계산 병리학 솔루션의 도입이 진행되고 있습니다. 주요 기술 기업, 연구기관, 디지털 병리 솔루션 제공업체들의 적극적인 참여와 더불어 AI 진단 기술에 대한 규제적 지원책이 시장 성장을 더욱 강화시키고 있습니다. 또한, 업무 효율화, 진단 결과의 표준화, 임상적 판단의 고도화에 대한 중요성이 높아지면서 병원, 진단 검사실, 연구기관에서의 도입이 가속화되고 있습니다.

예를 들어, IntuitionLabs의 '병원의 AI: 2025년 도입 동향 및 통계' 보고서에 따르면, 2024년까지 미국 비연방 급성기 병원의 약 71%가 전자건강기록(EHR) 시스템과 통합된 예측 AI 솔루션을 도입하여 2023년의 66%보다 증가했습니다. 이는 병원 환경 전반에 걸쳐 AI 도입이 가속화되고 있음을 보여줍니다. 같은 기간, 2024년 미국 의사의 66%가 임상 현장에서 AI 기반 도구를 사용하고 있다고 보고했으며, 이는 2023년에 비해 78% 증가한 수치입니다. 이러한 광범위한 보급은 미국 의료기관 전반에서 임상적 의사결정, 진단, 업무 효율화를 지원하는 AI의 역할이 확대되고 있음을 보여줍니다.

목차

제1장 계산 병리학 시장 개요

제2장 주요 요약

제3장 계산 병리학의 주요 시장 동향

제4장 계산 병리학 시장 : 산업 분석

제5장 계산 병리학 시장 : 높아지는 지정학적 긴장의 영향

제6장 계산 병리학 시장 구도

제7장 계산 병리학 시장 : 기술별

제8장 계산 병리학 시장 : 제품 종류별

제9장 계산 병리학 시장 : 워크플로우 단계별

제10장 계산 병리학 시장 : 전개 방식별

제11장 계산 병리학 시장 : 최종사용자별

제12장 계산 병리학 시장 : 지역별

제13장 주요 벤더 분석 : 계산 병리학 산업

제14장 AnalystView의 전방위적 분석

KSM 26.03.13

Computational Pathology Market size was valued at US$ 650.98 Million in 2024, expanding at a CAGR of 9.30% from 2025 to 2032.

Computational Pathology refers to an advanced digital system designed to assist healthcare organizations and pathologists by providing automated support for diagnostic, analytical, and operational activities. It leverages technologies such as artificial intelligence (AI), machine learning (ML), and image recognition to analyze digital pathology slides, detect patterns, quantify biomarkers, and generate actionable insights. These systems help improve diagnostic accuracy, reduce human error, and streamline pathology workflows, enabling faster turnaround times for lab results. By automating routine tasks such as image segmentation and data annotation, computational pathology reduces manual effort and enhances laboratory efficiency. It also supports clinical decision-making by providing precise, data-driven insights to pathologists and clinicians. Moreover, computational pathology solutions facilitate the expansion of accessible and digitally enabled diagnostic services, improving patient outcomes and supporting large-scale research initiatives in healthcare.

Computational Pathology Market- Market Dynamics

Increasing use of digital pathology platforms

Increasing use of digital pathology platforms refers to the growing adoption of advanced digital systems that allow pathologists and healthcare organizations to manage, analyze, and share pathology data more efficiently. It enables the integration of high-resolution pathology images, AI algorithms, and analytical applications within laboratory and clinical environments, improving diagnostic accuracy and workflow efficiency. In computational pathology, these platforms support automated image analysis, real-time data interpretation, and quantitative assessment of tissue samples. Consequently, pathologists can generate faster insights, reduce manual workloads, and enhance overall diagnostic performance. Moreover, the integration of digital pathology platforms with laboratory information systems (LIS) and electronic health records (EHRs) ensures seamless data flow and interoperability. These platforms also facilitate continuous learning and improvement of AI models through data-driven feedback. Overall, the increasing use of digital pathology platforms strengthens the scalability, reliability, and effectiveness of computational pathology solutions in modern healthcare systems. For instance, according to a September 2025 Frontiers in Digital Health study Organization's on digital pathology adoption in Jordan, 69.2 % of surveyed pathologists demonstrated average or above average knowledge of digital pathology, and 85 % expressed interest in using digital pathology tools for diagnostic purposes if available, reflecting strong professional readiness and interest in expanding digital pathology in emerging healthcare settings. These statistics reflect a sustained trend toward integrating digital pathology technologies to improve diagnostic processes, education, remote access, and research capabilities in clinical settings.

Computational Pathology Market- Segmentation Analysis:

The Global Computational Pathology Market is segmented on the basis of Technology, Product Type, Workflow Stage, Deployment Mode, End User, and Region.

The market is commonly divided into three categories based on Workflow Stage: Pre-Analytical, Analytical, and Post-Analytical. The Analytical stage accounts for a significant portion of the Computational Pathology market due to its role in enabling accurate AI-driven image analysis, efficient pathology interpretation, and timely diagnostic reporting. Diagnostic reporting refers to the process of documenting and communicating the results of medical tests or analyses, such as pathology findings, in a clear and structured format to guide clinical decision-making and patient care. This involves optimizing image analysis, streamlining pathology workflows, and accelerating diagnostic processes to ensure timely and accurate results. Enhancing analytical efficiency improves diagnostic accuracy, reduces workload for pathologists, and enables laboratories to process more samples effectively. In computational pathology, efficiency in the Analytical stage is achieved through AI-driven image interpretation, automated quantification of tissue features, and rapid report generation. These systems help pathologists analyze, validate, and finalize diagnostic findings quickly, minimize manual errors, and ensure faster, more reliable access to critical pathology results. For instance, a 2025 study published in PNAS Nexus Organization reported that a compact convolutional neural network achieved a diagnostic classification accuracy (AUC) of around 0.87 when differentiating normal lymph nodes from various lymphoma subtypes using standard histological images, highlighting the strong potential of efficient AI-driven computational pathology tools for clinical application.

The Computational Pathology market is divided into two categories based on Technology: AI-Based Technologies and Image Analysis & Visualization Technologies. The AI-Based Technologies segment accounts for a significant portion of the Computational Pathology market due to its ability to enhance diagnostic accuracy, scalability, and analytical efficiency. This growth is partly driven by rising healthcare investments and increasing adoption of advanced digital technologies in pathology workflows. Scalability and analytical capability in AI-based technologies refer to the ability of algorithms to process large volumes of pathology images efficiently while maintaining consistent performance across growing datasets. This enables laboratories to expand diagnostic capacity without proportional increases in manual effort or infrastructure complexity. In computational pathology, AI-based technologies allow automated image analysis, pattern recognition, and quantitative assessment of tissue samples at scale. These solutions support faster diagnoses, reduce pathologist workload, and enable continuous performance improvement through learning from expanding data, ensuring reliable and efficient pathology services across clinical and research settings. For instance, according to the UK government's Artificial Intelligence Sector Study 2024, the United Kingdom's AI ecosystem expanded significantly between 2023 and 2024, with total AI sector revenue rising to approximately 68 % increase from the previous year and AI-related employment growing to 86,139 jobs, underscoring rapid economic growth and adoption of AI technologies across industries. This extensive adoption underscores the growing maturity of digital pathology infrastructure and reflects broader trends in which AI-based technologies are enabling scalable analysis of pathology data, improved interoperability across diagnostic systems, and the expanded use of intelligent computational pathology solutions to support accurate, efficient, and data-driven clinical decision-making.

Computational Pathology Market- Geographical Insights

The Computational Pathology market shows notable regional differences, largely driven by variations in healthcare infrastructure, digital pathology adoption, and regulatory environments. North America continues to dominate the market, supported by advanced diagnostic facilities, early integration of AI-based pathology solutions, strong research ecosystems, and high adoption rates in the U.S. and Canada. Europe experiences consistent growth due to rising investments in precision diagnostics, favorable regulatory support for digital pathology, and increasing use of AI across pathology workflows. Asia Pacific represents a rapidly expanding market, propelled by accelerating healthcare digitalization, growing cancer burden, increasing AI investments, and supportive government initiatives in countries such as China, India, Japan, and South Korea. In comparison, Latin America, the Middle East, and Africa are witnessing gradual market development, supported by improving laboratory capabilities, growing awareness of computational pathology tools, and efforts to enhance diagnostic efficiency and accessibility.

United States Healthcare Virtual Assistant Market - Country Insights

The U.S. Computational Pathology market is experiencing consistent growth, driven by a sophisticated healthcare infrastructure and the increasing integration of AI-based diagnostic technologies. Healthcare providers and pathology laboratories are adopting computational pathology solutions to improve diagnostic precision, optimize laboratory workflows, and advance precision medicine. Active participation from major technology companies, research institutions, and digital pathology solution providers, along with supportive regulatory developments for AI-enabled diagnostics, is further strengthening market growth. In addition, the rising emphasis on operational efficiency, standardized diagnostic outcomes, and enhanced clinical decision-making is accelerating adoption across hospitals, diagnostic labs, and research organizations.

For example, according to IntuitionLabs' AI in Hospitals: 2025 Adoption Trends & Statistics report, by 2024 nearly 71 % of non-federal acute-care hospitals in the United States had implemented predictive AI solutions integrated with electronic health record (EHR) systems, an increase from 66 % in 2023, highlighting the accelerating adoption of AI across hospital environments. During the same period, 66 % of U.S. physicians reported using AI-based tools in clinical practice in 2024, reflecting a 78 % rise compared to 2023. This widespread uptake demonstrates the growing role of AI in supporting clinical decision-making, diagnostics, and operational efficiency across U.S. healthcare institutions.

Computational Pathology Market- Competitive Landscape:

The Computational Pathology Market is moderately concentrated, with several leading medical imaging, digital pathology, and AI-focused healthcare technology companies shaping the competitive landscape. Key players include Roche Diagnostics, Philips Healthcare, Siemens Healthineers, GE Healthcare, Leica Biosystems, Hamamatsu Photonics, Olympus Corporation, 3DHISTECH, Indica Labs, PathAI, Paige AI, Proscia, Visiopharm, Aiforia Technologies, and Ibex Medical Analytics. These companies compete by offering advanced AI-driven computational pathology solutions for whole slide imaging, image analysis, tumor detection, biomarker quantification, and diagnostic decision support. For example, in 2024 Proscia advanced its Concentriq AP platform by expanding cloud-enabled digital pathology workflows and supporting multi-AI model integration, allowing pathologists to access insights from multiple AI algorithms within a unified environment. These enhancements improved slide analysis speed, diagnostic consistency, and collaboration across distributed laboratory networks. Market momentum is being driven by growing demand for precise diagnostics, automated workflows, and precision medicine applications, particularly in oncology and research. In parallel, Proscia continues to strengthen its platform with advanced AI-driven image analytics, deeper integration with laboratory information systems (LIS), regulatory-compliant software updates, and scalable cloud infrastructure, addressing the evolving requirements of pathology laboratories, hospitals, and research institutions seeking efficient, reliable, and data-centric pathology solutions.

Recent Developments:

In 2025, Roche received Breakthrough Device Designation from the U.S. FDA for its VENTANA TROP2 RxDx computational pathology companion diagnostic, reinforcing its role in advancing AI-driven precision oncology diagnostics. At the same time, PathAI launched a multi-year collaboration with Northwestern Medicine to implement its AISight image management system, aimed at enhancing diagnostic accuracy, workflow efficiency, and consistency across clinical pathology operations. These developments highlight the growing impact of computational pathology in clinical decision-making and demonstrate how strategic partnerships and regulatory advancements are driving next-generation diagnostic solutions.

In 2025, PathAI expanded FDA clearance for its AISight(R) Dx digital pathology image management system to include additional whole-slide scanners through a Predetermined Change Control Plan (PCCP). This achievement made AISight(R) Dx one of the first AI/ML pathology platforms to secure this regulatory approval pathway, improving interoperability, enabling broader lab adoption, and supporting scalable implementation in diverse pathology environments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPUTATIONAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Leica Biosystems Nussloch GmbH
  • Hamamatsu Photonics K.K
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Aiforia Technologies PLC
  • Epredia
  • Visiopharm A/S
  • Proscia Inc.
  • Mindpeak GmbH
  • Others

GLOBALCOMPUTATIONAL PATHOLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Deep Learning and Neural Networks
  • Machine Learning (Non-Deep Learning)
  • Computer Vision and Image Processing
  • Cloud Computing and Edge Computing
  • Predictive and Prescriptive Analytics
  • Big Data and High-Performance Computing (HPC)

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032

  • Pre-Analytical
  • Analytical
  • Post-Analytical

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY DEPLOYMENT MODE - MARKET ANALYSIS, 2019 - 2032

  • On-Premises
  • Cloud-Based

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Diagnostic Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Research Institutes and Academic Centers

GLOBAL COMPUTATIONAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Computational Pathology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Computational Pathology Market Snippet by Technology
    • 2.1.2. Computational Pathology Market Snippet by Product Type
    • 2.1.3. Computational Pathology Market Snippet by Workflow Stage
    • 2.1.4. Computational Pathology Market Snippet by Deployment Mode
    • 2.1.5. Computational Pathology Market Snippet by End User
    • 2.1.6. Computational Pathology Market Snippet by Country
    • 2.1.7. Computational Pathology Market Snippet by Region
  • 2.2. Competitive Insights

3. Computational Pathology Key Market Trends

  • 3.1. Computational Pathology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Computational Pathology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Computational Pathology Market Opportunities
  • 3.4. Computational Pathology Market Future Trends

4. Computational Pathology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Computational Pathology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Computational Pathology Market Landscape

  • 6.1. Computational Pathology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Computational Pathology Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 7.1.2. Deep Learning and Neural Networks
    • 7.1.3. Machine Learning (Non-Deep Learning)
    • 7.1.4. Computer Vision and Image Processing
    • 7.1.5. Cloud Computing and Edge Computing
    • 7.1.6. Predictive and Prescriptive Analytics
    • 7.1.7. Big Data and High-Performance Computing (HPC)

8. Computational Pathology Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
    • 8.1.2. Software
    • 8.1.3. Services
    • 8.1.4. Hardware

9. Computational Pathology Market - By Workflow Stage

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Workflow Stage, 2024&2032 (%)
    • 9.1.2. Pre-Analytical
    • 9.1.3. Analytical
    • 9.1.4. Post-Analytical

10. Computational Pathology Market - By Deployment Mode

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
    • 10.1.2. On-Premises
    • 10.1.3. Cloud-Based

11. Computational Pathology Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 11.1.2. Hospitals and Diagnostic Laboratories
    • 11.1.3. Biotechnology & Pharmaceutical Companies
    • 11.1.4. Research Institutes and Academic Centers

12. Computational Pathology Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Computational Pathology Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Computational Pathology Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Computational Pathology Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APACMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.5. APACMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APACMarket Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.4.7. APACMarket Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.4.8. APACMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. PhilippinesMarket Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.4. PhilippinesMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. PhilippinesMarket Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.16.6. PhilippinesMarket Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.16.7. PhilippinesMarket Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Computational Pathology Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Computational Pathology Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Computational Pathology Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Leica Biosystems Nussloch GmbH
    • 13.2.2. Hamamatsu Photonics K.K
    • 13.2.3. Koninklijke Philips N.V.
    • 13.2.4. F. Hoffmann-La Roche Ltd.
    • 13.2.5. Aiforia Technologies PLC
    • 13.2.6. Epredia
    • 13.2.7. Visiopharm A/S
    • 13.2.8. Proscia Inc.
    • 13.2.9. Mindpeak GmbH
    • 13.2.10. Others

14. 360 Degree AnalystView

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제